"The Frequency and Clinical Consequences of Disruptions Encountered in the Planned Chemotherapy of AIDS Related Kaposi's Sarcoma."

According to an abstract submitted by the authors to the 1st National AIDS Malignancy Conference, held April 28-30, 1997, in Bethesda, Maryland, "Background: Epidemic KS is an aggressive AIDS-defining malignancy that now occurs in approximately 9% of people with AIDS. It is associated with significant morbidity and, when in advanced stages, may cause death. Aggressive therapy is usually poorly tolerated, and planned treatment delays are common. The presence of AIDS related infections complicates the management of the KS. Their development during KS treatment frequently shifts treatment priorities. We evaluated the care of individuals with KS to determine both how often...

Want to see the full article?

• Purchase this article for only $3.00